Half-year report · HY
6036.TEDINET S100XLNY
Period2025-07-01 → 2025-12-31
Filed2026-02-16
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.9bn | 2025-07-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥23.1bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2024-07-01 → 2024-12-31 | Standalone | Net sales |
| Operating income | ¥3.7bn | 2025-07-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥4.0bn | 2024-07-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥3.7bn | 2025-07-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.7bn | 2025-07-01 → 2025-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.1bn | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.0bn | 2024-07-01 → 2024-12-31 | Standalone | Ordinary income |
| Profit before tax | ¥10.4bn | 2025-07-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.0bn | 2024-07-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥7.2bn | 2025-07-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥4.9bn | 2024-07-01 → 2025-06-30 | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.7bn | 2024-07-01 → 2024-12-31 | Standalone | Profit loss |
| Total assets | ¥32.8bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥24.8bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥20.7bn | at 2024-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥9.3bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2025-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥23.6bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥18.0bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥15.8bn | at 2024-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥13.9bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.2bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥13.9bn | at 2025-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2024-06-30v | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2025-07-01 → 2025-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.9bn | 2024-07-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2024-07-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥10.4bn | 2025-07-01 → 2025-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.8bn | 2024-07-01 → 2025-06-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2025-07-01 → 2025-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥28m | 2024-07-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥265.2 | 2025-07-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.14 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.66 | 2024-07-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥60 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 71.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.5% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 28,280,840 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,280,840 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,280,840 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥334m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥334m |
| Kee Per LABO Operationreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥7.1bn |
| Kee Per LABO Operationreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥7.1bn |
| Kee Per LABO Operationreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥1.3bn |
| Kee Per Products And Others Relatedreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥6.1bn |
| Kee Per Products And Others Relatedreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥5.8bn |
| Kee Per Products And Others Relatedreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥334m |
| Kee Per Products And Others Relatedreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥2.4bn |
| —segment total | revenue | 2025-07-01 → 2025-12-31 | ¥13.3bn |
| —segment total | revenue external | 2025-07-01 → 2025-12-31 | ¥12.9bn |
| —segment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥334m |
| —segment total | segment profit | 2025-07-01 → 2025-12-31 | ¥3.7bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥277m |
| Kee Per LABO Operationreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| Kee Per LABO Operationreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| Kee Per LABO Operationreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥1.7bn |
| Kee Per Products And Others Relatedreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥5.8bn |
| Kee Per Products And Others Relatedreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.5bn |
| Kee Per Products And Others Relatedreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥277m |
| Kee Per Products And Others Relatedreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
| —segment total | revenue | 2024-07-01 → 2024-12-31 | ¥12.4bn |
| —segment total | revenue external | 2024-07-01 → 2024-12-31 | ¥12.1bn |
| —segment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥277m |
| —segment total | segment profit | 2024-07-01 → 2024-12-31 | ¥4.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 519
| Item | Context | Value | Unit |
|---|---|---|---|
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in accounting estimates semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | InterimInstant_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc type1 semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Other information financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |